Danaher Co. (NYSE:DHR – Free Report) – Analysts at Zacks Research lowered their Q2 2025 earnings estimates for shares of Danaher in a research report issued to clients and investors on Thursday, November 21st. Zacks Research analyst R. Department now anticipates that the conglomerate will earn $1.90 per share for the quarter, down from their previous forecast of $1.91. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Zacks Research also issued estimates for Danaher’s Q4 2025 earnings at $2.33 EPS and FY2025 earnings at $8.22 EPS.
Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm had revenue of $5.80 billion for the quarter, compared to the consensus estimate of $5.59 billion. During the same period last year, the firm posted $2.02 earnings per share. The company’s revenue for the quarter was up 3.1% on a year-over-year basis.
Read Our Latest Analysis on DHR
Danaher Price Performance
DHR stock opened at $235.84 on Monday. Danaher has a 1 year low of $215.68 and a 1 year high of $281.70. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $170.34 billion, a PE ratio of 45.01, a price-to-earnings-growth ratio of 4.32 and a beta of 0.85. The business has a 50 day simple moving average of $258.15 and a 200-day simple moving average of $260.03.
Institutional Investors Weigh In On Danaher
Several large investors have recently modified their holdings of the company. Anchor Investment Management LLC grew its position in Danaher by 1.3% during the 3rd quarter. Anchor Investment Management LLC now owns 6,039 shares of the conglomerate’s stock worth $1,679,000 after purchasing an additional 78 shares during the last quarter. Tudor Financial Inc. acquired a new stake in shares of Danaher during the third quarter worth about $414,000. Discipline Wealth Solutions LLC purchased a new position in shares of Danaher during the third quarter worth about $314,000. Soltis Investment Advisors LLC increased its position in Danaher by 19.3% in the 3rd quarter. Soltis Investment Advisors LLC now owns 1,563 shares of the conglomerate’s stock valued at $434,000 after acquiring an additional 253 shares during the period. Finally, TD Private Client Wealth LLC raised its stake in Danaher by 1.0% during the 3rd quarter. TD Private Client Wealth LLC now owns 17,946 shares of the conglomerate’s stock valued at $4,989,000 after acquiring an additional 169 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
- Five stocks we like better than Danaher
- What is a SEC Filing?
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Top Biotech Stocks: Exploring Innovation Opportunities
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Canadian Penny Stocks: Can They Make You Rich?
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.